Use of 50% Nitrous Oxide / 50% Oxygen Premix During Liver Biopsy of Focal Lesion
Study of the Efficiency of Kalinox 170 Bar During Liver Biospy of Focal Lesion
1 other identifier
interventional
94
1 country
1
Brief Summary
A 50% nitrous oxide / 50% oxygen premix is administrated to the patient during the realization of liver biopsy in order to relax him and to reduce his pain during this painful medical treatment. This single investigator centre and national clinical trial is done blindly : half of patients will receive 50% nitrous oxide / 50% oxygen premix and half of them a placebo gas (mixture of 50% oxygen and 50% nitrogen). 94 patients will be included in this clinical protocol.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4
Started Oct 2007
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2007
CompletedFirst Submitted
Initial submission to the registry
March 19, 2008
CompletedFirst Posted
Study publicly available on registry
March 26, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2008
CompletedMarch 13, 2025
March 1, 2025
8 months
March 19, 2008
March 11, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain measurement by using Visual Analog Scale (VAS)
At the end of the liver biospy
Secondary Outcomes (1)
Patient's acceptance and doctor's satisfaction
At the end of the liver biopsy
Study Arms (2)
A
EXPERIMENTALMixture of 50% nitrous oxide and 50% oxygen
B
PLACEBO COMPARATORMixture of 50% oxygen and 50% nitrogen
Interventions
Flow of gas administrated to the patient between 4 and 15 litre/min and less than 1 hour
Flow of gas administrated to the patient between 4 and 15 litre/min and less than 1 hour
Eligibility Criteria
You may qualify if:
- patient requiring a liver biopsy of focal lesion
- Age upper than 18 years
- OMS : 0 to 3
- patient consent form signed
You may not qualify if:
- patient unable to use Visual Analog Scale (VAS)
- OMS upper than 3
- coagulation disorder
- contraindication linked to the experimental product
- patient already included in another clinical trial uncompatible with this trial
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Beaujon hospital
Clichy, 92118, France
Related Publications (1)
Meskine N, Vullierme MP, Zappa M, d'Assignies G, Sibert A, Vilgrain V. Evaluation of analgesic effect of equimolar mixture of oxygen and nitrous oxide inhalation during percutaneous biopsy of focal liver lesions: a double-blind randomized study. Acad Radiol. 2011 Jul;18(7):816-21. doi: 10.1016/j.acra.2011.01.025. Epub 2011 Apr 20.
PMID: 21511500BACKGROUND
Related Links
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 19, 2008
First Posted
March 26, 2008
Study Start
October 1, 2007
Primary Completion
June 1, 2008
Study Completion
December 1, 2008
Last Updated
March 13, 2025
Record last verified: 2025-03